Key Takeaways
- THC has well-documented sedative and hypnotic effects -- but the strength of those effects depends on dose, frequency, and individual tolerance, not on whether a product is labeled "indica"
- A large naturalistic study of nearly 1,000 people with insomnia found THC-dominant products were rated more effective for sleep than CBD-dominant ones
- CBD alone shows mixed results: most users in a small survey reported better sleep after a month, but about a quarter reported it got worse
- What predicts a calming evening effect is the THC:CBD ratio and terpene profile of a specific product -- not the strain name on the label
- Frequent, high-dose use can build tolerance and disrupt sleep over time, so starting low and going slow matters even for sleep
If you've ever asked a budtender for "something to help me sleep," you've probably been pointed toward an indica. The problem is that indica and sativa labels describe a plant's growth pattern and geographic origin, not its chemical effects, and lab testing has repeatedly found little correlation between the label and the cannabinoid or terpene profile of what's actually in the package. So while "indica" might feel like useful shorthand, it isn't something cannabis research actually validates as a predictor of effect.
What the science does support is that THC and CBD content, along with the terpene profile, are what drive how a product affects you in the evening.
THC's sedative properties are some of the best-documented effects in cannabis pharmacology. A 2020 narrative review in Frontiers in Molecular Neuroscience (Kesner & Lovinger) describes THC's acute hypnotic and sleep-promoting effects as well-established -- though the review is also clear that these effects vary considerably depending on dose, frequency of use, age, and individual tolerance. In other words: THC can help you fall asleep, but how much it helps (and for how long) isn't the same for everyone.
The largest real-world evidence comes from a 2021 naturalistic study published in the Journal of Medical Internet Research (Kuhathasan et al.), which used an app to track 991 people with insomnia across 24,189 individual sessions. Products that were THC-dominant -- commonly labeled "indica" -- were rated as significantly more effective for symptom relief than CBD-dominant products. A follow-up 2022 study from the same research group, published in BMC Psychiatry and covering 677 sessions among people with depression or anxiety, found cannabis broadly perceived as helpful for winding down, with dried flower and oral oils rated as the most useful formats.
It's worth being upfront about the limits of this evidence: both studies rely on self-reported, naturalistic data from an app, not controlled lab conditions. That means placebo effects, expectation, and recall bias could all be playing a role. They tell us what people experience, not necessarily what's happening pharmacologically in a controlled setting.
CBD's reputation as a sleep aid is more mixed than THC's. A frequently cited survey of 72 adults found that about two-thirds reported improved sleep after a month of CBD use -- but roughly a quarter reported their sleep got worse. That split outcome lines up with what's sometimes called CBD's biphasic effect: at low doses, some people find it mildly alerting, while at higher doses it tends to be more sedating. If you've tried CBD for sleep and it didn't work -- or backfired -- dose may be a bigger factor than the product itself.
Most of what we know about cannabis and sleep comes from observational or self-reported data. One exception is a 2025 randomized, placebo-controlled trial (Narayan et al., published in Clinical Drug Investigation) that tested low-dose THC:CBD oil formulations -- in 1:1 and 1:16 ratios -- in cannabis-naive participants. The sample was small (20 people), so it's best treated as a preliminary signal rather than a definitive answer, but it's notable for being one of the few controlled studies specifically designed around evening, sedative use in people new to cannabis.
Beyond THC and CBD, the terpene profile of a product is often cited as shaping its overall effect -- and two terpenes come up again and again in discussions of evening use: myrcene, found in high concentrations in strains like Blue Dream, and linalool, also found in lavender and associated with calming effects in aromatherapy research. It's worth being honest about the evidence gap here: while there's a reasonable mechanistic case for terpenes contributing to a product's overall effect (often called the "entourage effect"), there isn't yet a large body of human clinical trials isolating specific terpenes for sleep. If a product's lab report shows its terpene content, myrcene and linalool are reasonable things to look for -- just don't expect them to override a THC:CBD ratio that doesn't suit you.
If you're looking for an evening product to help you wind down, the research points toward THC-containing products -- particularly higher-THC or balanced THC:CBD options -- as more likely to produce a noticeable calming effect than CBD alone, based on the best available real-world evidence. But "indica" on the label tells you very little; the THC:CBD ratio and terpene profile of the specific product you're holding tell you much more. Start low, pay attention to how a product actually makes you feel, and don't assume more is always better -- especially if you're using cannabis regularly for sleep.
This article is for informational purposes only and is not medical advice. If you have a diagnosed sleep disorder or are taking other medications, talk to a healthcare provider before using cannabis as a sleep aid.
Last updated: June 2026 | Based on: peer-reviewed research and naturalistic studies from DeepWeed's knowledge base, including a 991-person naturalistic study and a 2025 randomized controlled trial